New Zealand hospitalisations due to agents primarily acting on muscles and respiration causing adverse effects
By sex and age group, year ended June 2022, number of patients discharged (publicly funded)
Sex | Age group | Number of hospitalisations |
---|---|---|
Female | 10-14 | 2 |
Female | 15-19 | 16 |
Female | 20-24 | 18 |
Female | 25-29 | 16 |
Female | 30-34 | 31 |
Female | 35-39 | 25 |
Female | 0-4 | 10 |
Female | 40-44 | 8 |
Female | 45-49 | 9 |
Female | 50-54 | 11 |
Female | 55-59 | 10 |
Female | 5-9 | 6 |
Female | 60-64 | 6 |
Female | 65-69 | 8 |
Female | 70-74 | 14 |
Female | 75-79 | 9 |
Female | 80-84 | 5 |
Female | 85+ | 6 |
Male | 10-14 | 5 |
Male | 15-19 | 0 |
Male | 20-24 | 1 |
Male | 25-29 | 4 |
Male | 30-34 | 0 |
Male | 35-39 | 1 |
Male | 0-4 | 13 |
Male | 40-44 | 1 |
Male | 45-49 | 2 |
Male | 50-54 | 8 |
Male | 55-59 | 7 |
Male | 5-9 | 8 |
Male | 60-64 | 5 |
Male | 65-69 | 6 |
Male | 70-74 | 10 |
Male | 75-79 | 9 |
Male | 80-84 | 2 |
Male | 85+ | 4 |